{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:33:19Z","timestamp":1793503999364,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100018847","name":"Sel\u00e7uk University Research Foundation","doi-asserted-by":"publisher","award":["24122020"],"award-info":[{"award-number":["24122020"]}],"id":[{"id":"10.13039\/501100018847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-37306-3","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T15:24:14Z","timestamp":1771255454000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Beyond glycemia: adropin, asprosin, and irisin as potential biomarkers for cardiovascular risk in diabetes and prediabetes"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-3849-1680","authenticated-orcid":false,"given":"Esra","family":"Karap\u0131nar G\u00f6ze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5433-168X","authenticated-orcid":false,"given":"Bahar","family":"\u00dcr\u00fcn \u00dcnal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9991-3939","authenticated-orcid":false,"given":"Ali","family":"\u00dcnl\u00fc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1033-8935","authenticated-orcid":false,"given":"\u0130rem","family":"A\u00e7\u0131lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"37306_CR1","doi-asserted-by":"publisher","unstructured":"American Diabetes Association Professional Practice Committee. 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes\u20142025. Diabetes Care. 48(Suppl 1):S207\u2013S238. (2025). https:\/\/doi.org\/10.2337\/dc25-S010","DOI":"10.2337\/dc25-S010"},{"key":"37306_CR2","unstructured":"International Diabetes Federation. IDF Diabetes Atlas 10th edn (International Diabetes Federation, 2021)."},{"key":"37306_CR3","unstructured":"International Diabetes Federation. IDF Diabetes Atlas 11th edn (International Diabetes Federation, 2025)."},{"issue":"6","key":"37306_CR4","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.cmet.2008.10.011","volume":"8","author":"KG Kumar","year":"2008","unstructured":"Kumar, K. G. et al. Identification of Adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism. Cell. Metab. 8 (6), 468\u2013481. https:\/\/doi.org\/10.1016\/j.cmet.2008.10.011 (2008).","journal-title":"Cell. Metab."},{"issue":"3","key":"37306_CR5","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.cell.2016.02.063","volume":"165","author":"C Romere","year":"2016","unstructured":"Romere, C. et al. Asprosin, a fasting-induced glucogenic protein hormone. Cell 165 (3), 566\u2013579. https:\/\/doi.org\/10.1016\/j.cell.2016.02.063 (2016).","journal-title":"Cell"},{"issue":"8","key":"37306_CR6","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1007\/s40618-024-02360-z","volume":"47","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y., Yang, P., Zhang, X., Liu, S. & Lou, K. Asprosin: its function as a novel endocrine factor in metabolic-related diseases. J. Endocrinol. Invest. 47 (8), 1839\u20131850. https:\/\/doi.org\/10.1007\/s40618-024-02360-z (2024).","journal-title":"J. Endocrinol. Invest."},{"key":"37306_CR7","doi-asserted-by":"publisher","unstructured":"Khan, S., Syeda, S., Raghuvanshi, Y. & Shrivastava, A. Pathophysiological insights into asprosin: an emerging adipokine in reproductive health. Rev Endocr. Metab. Disord 2025:1\u201326. https:\/\/doi.org\/10.1007\/s11154-025-09975-4","DOI":"10.1007\/s11154-025-09975-4"},{"issue":"7382","key":"37306_CR8","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nature10777","volume":"481","author":"P Bostr\u00f6m","year":"2012","unstructured":"Bostr\u00f6m, P. et al. A PGC1-\u03b1-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481 (7382), 463\u2013468. https:\/\/doi.org\/10.1038\/nature10777 (2012).","journal-title":"Nature"},{"key":"37306_CR9","unstructured":"Karap\u0131nar G\u00f6ze E. The relationship between serum adropin, asprosin and irisin levels and cardiovascular disease risk in healthy individuals, prediabetic and type 2 diabetes patients. Specialization in Medicine Thesis, Sel\u00e7uk University (2025)."},{"issue":"7","key":"37306_CR10","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews, D. R. et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (7), 412\u2013419. https:\/\/doi.org\/10.1007\/BF00280883 (1985).","journal-title":"Diabetologia"},{"issue":"1","key":"37306_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.5603\/EP.a2022.0093","volume":"74","author":"G Hu","year":"2023","unstructured":"Hu, G., Si, W., Zhang, Q. & Lv, F. Circulating asprosin, irisin, and abdominal obesity in Chinese patients with type 2 diabetes mellitus: a case\u2013control study. Endokrynol Pol. 74 (1), 55\u201362. https:\/\/doi.org\/10.5603\/EP.a2022.0093 (2023).","journal-title":"Endokrynol Pol."},{"key":"37306_CR12","doi-asserted-by":"publisher","unstructured":"Chew, S. M., Dua Avinashi, S. & Venkataraman, K. Predictors of incident diabetic peripheral neuropathy: a systematic review of longitudinal studies in diabetes mellitus. Rev Endocr. Metab. Disord 2025:1\u201319. https:\/\/doi.org\/10.1007\/s11154-025-09973-6","DOI":"10.1007\/s11154-025-09973-6"},{"key":"37306_CR13","unstructured":"Turkish Society of Endocrinology and Metabolism. TEMD Diabetes Mellitus and Complications Guidelines. Ankara. (2024). Available from: https:\/\/file.temd.org.tr\/Uploads\/publications\/guides\/documents\/diabetesmellitus2024.pdf. Accessed January 20, 2025."},{"issue":"19","key":"37306_CR14","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1001\/jama.241.19.2035","volume":"241","author":"WB Kannel","year":"1979","unstructured":"Kannel, W. B. & McGee, D. L. Diabetes and cardiovascular disease: the Framingham study. JAMA 241 (19), 2035\u20132038. https:\/\/doi.org\/10.1001\/jama.241.19.2035 (1979).","journal-title":"JAMA"},{"key":"37306_CR15","unstructured":"Framingham Heart Study. Coronary heart disease 10-year risk calculator. (2025). Available from: https:\/\/www.framinghamheartstudy.org\/fhs-risk-functions\/coronary-heart-disease-10-year-risk\/. Accessed March 10."},{"key":"37306_CR16","unstructured":"Alpar, R. Applied Statistics and Validity-Reliability with Examples from Sports, Health, and Education Sciences (Detay Publishing, 2018)."},{"issue":"7","key":"37306_CR17","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1507\/endocrj.EJ18-0060","volume":"65","author":"H Zang","year":"2018","unstructured":"Zang, H., Jiang, F., Cheng, X., Xu, H. & Hu, X. Serum Adropin levels are decreased in Chinese type 2 diabetic patients and negatively correlated with body mass index. Endocr. J. 65 (7), 685\u2013691. https:\/\/doi.org\/10.1507\/endocrj.EJ18-0060 (2018).","journal-title":"Endocr. J."},{"issue":"2","key":"37306_CR18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.5152\/eurasianjmed.2022.22128","volume":"54","author":"P Ayd\u0131n","year":"2022","unstructured":"Ayd\u0131n, P., Uzun\u00e7akmak, S. K., T\u00f6r, \u0130. H., Bilen, A. & \u00d6zden, A. Comparison of serum Adropin levels in diabetes mellitus, COVID-19, and COVID-19 with diabetes mellitus. Eurasian J. Med. 54 (2), 197\u2013202. https:\/\/doi.org\/10.5152\/eurasianjmed.2022.22128 (2022).","journal-title":"Eurasian J. Med."},{"issue":"1","key":"37306_CR19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11010-013-1660-4","volume":"380","author":"S Aydin","year":"2013","unstructured":"Aydin, S. et al. Expression of Adropin in rat organs in streptozotocin-induced diabetes. Mol. Cell. Biochem. 380 (1), 73\u201381. https:\/\/doi.org\/10.1007\/s11010-013-1660-4 (2013).","journal-title":"Mol. Cell. Biochem."},{"key":"37306_CR20","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.2147\/DMSO.S243755","volume":"13","author":"FY Kuo","year":"2020","unstructured":"Kuo, F. Y., Cheng, K-C., Li, Y., Cheng, J-T. & Tsai, C-C. Promotion of Adropin expression by hyperglycemia is associated with STAT3 activation in diabetic rats. Diabetes Metab. Syndr. Obes. 13, 2269\u20132277. https:\/\/doi.org\/10.2147\/DMSO.S243755 (2020).","journal-title":"Diabetes Metab. Syndr. Obes."},{"issue":"2","key":"37306_CR21","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1080\/13813455.2019.1684951","volume":"128","author":"A-A Palizban","year":"2022","unstructured":"Palizban, A-A., Yazdani, A-H. & Jahanbani-Ardakani, H. Role of rs7903146 polymorphism and Adropin serum level in diabetes mellitus: a case\u2013control study. Arch. Physiol. Biochem. 128 (2), 378\u2013381. https:\/\/doi.org\/10.1080\/13813455.2019.1684951 (2022).","journal-title":"Arch. Physiol. Biochem."},{"issue":"9","key":"37306_CR22","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1111\/1440-1681.12439","volume":"42","author":"S Tang","year":"2015","unstructured":"Tang, S. et al. Circulating Irisin and lipid and uric acid metabolism. Clin. Exp. Pharmacol. Physiol. 42 (9), 896\u2013901. https:\/\/doi.org\/10.1111\/1440-1681.12439 (2015).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"37306_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-017-0627-2","volume":"16","author":"KS Rana","year":"2017","unstructured":"Rana, K. S. et al. Plasma Irisin is elevated in type 2 diabetes and associated with E-selectin. Cardiovasc. Diabetol. 16, 1\u201310. https:\/\/doi.org\/10.1186\/s12933-017-0627-2 (2017).","journal-title":"Cardiovasc. Diabetol."},{"issue":"4","key":"37306_CR24","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.jdiacomp.2013.03.002","volume":"27","author":"J-J Liu","year":"2013","unstructured":"Liu, J-J. et al. Lower Circulating Irisin in type 2 diabetes mellitus. J. Diabetes Complications. 27 (4), 365\u2013369. https:\/\/doi.org\/10.1016\/j.jdiacomp.2013.03.002 (2013).","journal-title":"J. Diabetes Complications"},{"issue":"18","key":"37306_CR25","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.clinbiochem.2015.07.098","volume":"48","author":"ID Duran","year":"2015","unstructured":"Duran, I. D. et al. Irisin levels in diabetes progression in sedentary women. Clin. Biochem. 48 (18), 1268\u20131272. https:\/\/doi.org\/10.1016\/j.clinbiochem.2015.07.098 (2015).","journal-title":"Clin. Biochem."},{"issue":"6","key":"37306_CR26","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/s40618-020-01415-1","volume":"44","author":"T Miazgowski","year":"2021","unstructured":"Miazgowski, T., Kaczmarkiewicz, A. & Miazgowski, B. Kope\u0107. Cardiometabolic health, visceral fat and irisin: results from real-world weight loss study. J. Endocrinol. Invest. 44 (6), 1243\u20131252. https:\/\/doi.org\/10.1007\/s40618-020-01415-1 (2021).","journal-title":"J. Endocrinol. Invest."},{"issue":"10","key":"37306_CR27","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1007\/s40618-021-01529-0","volume":"44","author":"A Gaudio","year":"2021","unstructured":"Gaudio, A. et al. Effects of competitive physical activity on serum Irisin and bone turnover markers. J. Endocrinol. Invest. 44 (10), 2235\u20132241. https:\/\/doi.org\/10.1007\/s40618-021-01529-0 (2021).","journal-title":"J. Endocrinol. Invest."},{"key":"37306_CR28","doi-asserted-by":"publisher","first-page":"8889","DOI":"10.1038\/srep08889","volume":"5","author":"E Albrecht","year":"2015","unstructured":"Albrecht, E. et al. Irisin: a myth rather than an exercise-inducible myokine. Sci. Rep. 5, 8889. https:\/\/doi.org\/10.1038\/srep08889 (2015).","journal-title":"Sci. Rep."},{"issue":"4","key":"37306_CR29","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1210\/jc.2014-2932","volume":"100","author":"D L\u00f6ffler","year":"2015","unstructured":"L\u00f6ffler, D. et al. Serum Irisin levels are regulated by acute strenuous exercise. J. Clin. Endocrinol. Metab. 100 (4), 1289\u20131299. https:\/\/doi.org\/10.1210\/jc.2014-2932 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"37306_CR30","doi-asserted-by":"publisher","first-page":"9471583","DOI":"10.1155\/2018\/9471583","volume":"2018","author":"Y Wang","year":"2018","unstructured":"Wang, Y. et al. Plasma Asprosin levels in glucose dysregulation: correlation with insulin resistance. J. Diabetes Res. 2018, 9471583. https:\/\/doi.org\/10.1155\/2018\/9471583 (2018).","journal-title":"J. Diabetes Res."},{"key":"37306_CR31","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.cca.2018.11.006","volume":"489","author":"L Zhang","year":"2019","unstructured":"Zhang, L., Chen, C., Zhou, N., Fu, Y. & Cheng, X. Circulating Asprosin increased in T2DM and correlated with glucose and triglyceride. Clin. Chim. Acta. 489, 183\u2013188. https:\/\/doi.org\/10.1016\/j.cca.2018.11.006 (2019).","journal-title":"Clin. Chim. Acta"},{"key":"37306_CR32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13098-020-00564-w","volume":"12","author":"S Naiemian","year":"2020","unstructured":"Naiemian, S. et al. Serum Asprosin in new-onset T2DM. Diabetol. Metab. Syndr. 12, 42. https:\/\/doi.org\/10.1186\/s13098-020-00564-w (2020).","journal-title":"Diabetol. Metab. Syndr."},{"key":"37306_CR33","doi-asserted-by":"publisher","first-page":"857270","DOI":"10.1155\/2014\/857270","volume":"2014","author":"M Pardo","year":"2014","unstructured":"Pardo, M. et al. Association of Irisin with fat mass and energy expenditure in extreme BMI. J. Obes. 2014, 857270. https:\/\/doi.org\/10.1155\/2014\/857270 (2014).","journal-title":"J. Obes."},{"key":"37306_CR34","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.peptides.2012.11.014","volume":"39","author":"A Stengel","year":"2013","unstructured":"Stengel, A. et al. Irisin in anorexia nervosa and obesity stages. Peptides 39, 125\u2013130. https:\/\/doi.org\/10.1016\/j.peptides.2012.11.014 (2013).","journal-title":"Peptides"},{"key":"37306_CR35","doi-asserted-by":"publisher","first-page":"962968","DOI":"10.3389\/fendo.2022.962968","volume":"13","author":"S Liu","year":"2022","unstructured":"Liu, S. et al. Role of Irisin in physiology and pathology. Front. Endocrinol. 13, 962968. https:\/\/doi.org\/10.3389\/fendo.2022.962968 (2022).","journal-title":"Front. Endocrinol."},{"key":"37306_CR36","doi-asserted-by":"publisher","first-page":"14691","DOI":"10.1038\/srep14691","volume":"5","author":"AA Butler","year":"2015","unstructured":"Butler, A. A. et al. Plasma Adropin responses to glucose or Fructose. Sci. Rep. 5, 14691. https:\/\/doi.org\/10.1038\/srep14691 (2015).","journal-title":"Sci. Rep."},{"key":"37306_CR37","doi-asserted-by":"publisher","first-page":"6737318","DOI":"10.1155\/2019\/6737318","volume":"2019","author":"L Elizondo-Montemayor","year":"2019","unstructured":"Elizondo-Montemayor, L. et al. Irisin, hs-CRP, and metabolic status in T2DM youth. Mediators Inflamm. 2019, 6737318. https:\/\/doi.org\/10.1155\/2019\/6737318 (2019).","journal-title":"Mediators Inflamm."},{"issue":"7","key":"37306_CR38","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/iub.1511","volume":"68","author":"A Shoukry","year":"2016","unstructured":"Shoukry, A. et al. Serum Irisin in obesity and T2DM. IUBMB Life. 68 (7), 544\u2013556. https:\/\/doi.org\/10.1002\/iub.1511 (2016).","journal-title":"IUBMB Life"},{"issue":"2","key":"37306_CR39","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/jdi.13148","volume":"11","author":"X Zhang","year":"2020","unstructured":"Zhang, X., Jiang, H., Ma, X. & Wu, H. Increased Asprosin level and impaired glucose response in T2DM. J. Diabetes Investig. 11 (2), 349\u2013355. https:\/\/doi.org\/10.1111\/jdi.13148 (2020).","journal-title":"J. Diabetes Investig"},{"key":"37306_CR40","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.phrs.2018.01.012","volume":"129","author":"H Askari","year":"2018","unstructured":"Askari, H. et al. Therapeutic potential of irisin: inflammation, oxidative stress, apoptosis. Pharmacol. Res. 129, 44\u201355. https:\/\/doi.org\/10.1016\/j.phrs.2018.01.012 (2018).","journal-title":"Pharmacol. Res."},{"key":"37306_CR41","doi-asserted-by":"publisher","first-page":"1482308","DOI":"10.3389\/fimmu.2025.1482308","volume":"16","author":"J Wang","year":"2025","unstructured":"Wang, J. et al. Adropin: immune cell homeostasis and inflammation regulation. Front. Immunol. 16, 1482308. https:\/\/doi.org\/10.3389\/fimmu.2025.1482308 (2025).","journal-title":"Front. Immunol."},{"key":"37306_CR42","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.mce.2019.03.001","volume":"486","author":"T Lee","year":"2019","unstructured":"Lee, T., Yun, S., Jeong, J. H. & Jung, T. W. Asprosin impairs insulin secretion via TLR4\/JNK inflammation. Mol. Cell. Endocrinol. 486, 96\u2013104. https:\/\/doi.org\/10.1016\/j.mce.2019.03.001 (2019).","journal-title":"Mol. Cell. Endocrinol."},{"issue":"2","key":"37306_CR43","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s10753-022-01761-7","volume":"46","author":"Q Huang","year":"2023","unstructured":"Huang, Q. et al. Asprosin exacerbates endothelial inflammation via IKK\u03b2-NF-\u03baB pathway. Inflammation 46 (2), 623\u2013638. https:\/\/doi.org\/10.1007\/s10753-022-01761-7 (2023).","journal-title":"Inflammation"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37306-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37306-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37306-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T10:57:36Z","timestamp":1772189856000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37306-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["37306"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-37306-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"4 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Local Ethics Committee of Sel\u00e7uk University Faculty of Medicine (2024\/252).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"7745"}}